Advertisement

Photodynamic Therapy

  • Chakravarthy Reddy
Chapter

Abstract

Photodynamic therapy is a nonsurgical therapeutic option for the management of endobronchial tumors. It involves intravenous injection of a photosensitizing drug, followed by direct application of a nonthermal laser. The laser provides the wavelength of light to activate the drug in the tumor. Once activated, the drug causes cell death through oxygen free radical generation, small vessel thrombosis, and a tumor-specific cytotoxic immunity. The necrotic debris should be removed by bronchoscopy to avoid airway obstruction.

Photodynamic therapy is currently indicated in patients with microinvasive endobronchial non-small cell lung cancer (NSCLC) and comorbidities that render them ineligible for surgical resections, where it is used with a curative intent and in patients with completely or partially obstructing endobronchial NSCLC who require debulking of the airway tumor for palliation of symptoms. Photodynamic therapy is also useful in debulking endobronchial metastatic lesions from nonpulmonary malignancies.

The major adverse reaction following PDT is skin photosensitivity that can be avoided with meticulous pre- and postprocedure patient education. Other adverse reactions include transient local inflammatory response, airway stenosis at the site of treatment, and, rarely, massive hemoptysis. The utility of PDT in the management of lung cancers is only expected to expand as newer photosensitizing drugs are developed.

Keywords

Airway Obstruction Photodynamic Therapy Massive Hemoptysis Early Stage NSCLC Hematoporphyrin Derivative 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Suggested Reading

  1. 1.
    Dougherty TJ, Potter WR, Weishaupt KR. The structure of the active component of hematoporphyrin derivative. In: Doiron DR, Gomer CJ, editors. Porphyrin localization and treatment of tumors. New York: A.R. Liss. 1984; pp. 301–314.Google Scholar
  2. 2.
    Lipson RL, Blades EJ, Olsen AM. Hematoporphyrin derivative: a new aid for endoscopic detection of malignant disease. J Thorac Cardiovasc Surg. 1961;42:623–9.PubMedGoogle Scholar
  3. 3.
    Dougherty TJ, Kaufman JE, Goldfarb A, et al. Photoradiation therapy for the treatment of malignant tumors. Cancer Res. 1978;38:2628–35.PubMedGoogle Scholar
  4. 4.
    Hayata Y, Kato H, Konaka C, et al. Hematoporphyrin derivative and laser photoradiation in the treatment of lung cancer. Chest. 1982;81:269–71.PubMedCrossRefGoogle Scholar
  5. 5.
    Lo Cicero J, Metzdorff M, Almgren C. Photodynamic therapy in the palliation of late stage obstructing non-small cell lung cancer. Chest. 1990;98:97–100.CrossRefGoogle Scholar
  6. 6.
    Ackroyd R, Kelty C, Brown N, et al. The history of photodetection and photodynamic therapy. Photochem Photobiol. 2001;74(5):656–69.PubMedCrossRefGoogle Scholar
  7. 7.
    Gomer CJ, Dougherty TJ. Determination of [3H]- and [14C] hematoporphyrin derivative distribution in malignant and normal tissue. Cancer Res. 1979;39:146–51.PubMedGoogle Scholar
  8. 8.
    Dougherty TJ, Gomer CJ, Henderson BW, et al. Photodynamic therapy. J Natl Cancer Inst. 1998;90:889–905.PubMedCrossRefGoogle Scholar
  9. 9.
    Pass HI. Photodynamic therapy in oncology: mechanism and clinical use. J Natl Cancer Inst. 1993;8:443–56.CrossRefGoogle Scholar
  10. 10.
    Wieshaupt KR, Gomer CJ, Dougherty TJ. Identification of singlet oxygen as cytotoxic agent in photoinactivation of a murine tumor. Cancer Res. 1976;36:2326–9.Google Scholar
  11. 11.
    Kessel D, Luo Y. Mitochondrial photodamage and PDT-induced apoptosis. J Photochem Photobiol. 1998;42:89–95.CrossRefGoogle Scholar
  12. 12.
    Fingar VH. Vascular effects of photodynamic therapy. J Clin Laser Med Surg. 1996;14:323–8.PubMedGoogle Scholar
  13. 13.
    Korbelik M. Induction of tumor immunity by photodynamic therapy. J Clin Laser Med Surg. 1996;14:329–34.PubMedGoogle Scholar
  14. 14.
    Hayata H, Kato H, Konaka C, et al. Photoradiation therapy with haematoporphyrin derivative in early and stage I lung cancer. Chest. 1982;81:269–77.PubMedCrossRefGoogle Scholar
  15. 15.
    Moghissi K, Dixon K. Update on the current indications, practice and results of photodynamic therapy (PDT) in early central lung cancer (ECLC). Photodiagnosis Photodyn Ther. 2008;5:10–8.PubMedCrossRefGoogle Scholar
  16. 16.
    Kennedy TC, McWilliams A, Edell E, et al. Bronchial intraepithelial neoplasia/early central airways lung cancer: ACCP evidence-based clinical practice guidelines (2nd ed). Chest. 2007;132:221–33.CrossRefGoogle Scholar
  17. 17.
    Koike T, Terashima M, Takizawa T, et al. Surgical results for centrally located early stage lung cancer. Ann Thorac Surg. 2000;70:1176–9.PubMedCrossRefGoogle Scholar
  18. 18.
    Terzi A, Pelosi G, Falezza G, et al. Early hilar lung cancer clinical aspect and long term survival – identification of sub group IA patients with more favorable prognosis. Lung Cancer. 2000;27:119–24.PubMedCrossRefGoogle Scholar
  19. 19.
    Ernst A, Feller-Kopman D, Becker HD, et al. Central airway obstruction. Am J Respir Crit Care Med. 2004;169:1278–97.PubMedCrossRefGoogle Scholar
  20. 20.
    Shah SK, Ost D. Photodynamic therapy: a case series demonstrating its role in patients receiving mechanical ventilation. Chest. 2000;118:1419–23.PubMedCrossRefGoogle Scholar
  21. 21.
    Lam S, Grafton C, Coy P, et al. Combined photodynamic therapy (PDT) using photofrin and radiotherapy (XRT) versus radiotherapy alone in patients with inoperable obstructive non-small cell bronchogenic carcinoma. SPIE. 1991;1616:20–8.CrossRefGoogle Scholar
  22. 22.
    Moghissi K, Dixon K, Hudson E, et al. Endoscopic laser therapy in malignant tracheobronchial obstruction using sequential Nd:YAG laser and photodynamic therapy. Thorax. 1997;52:281–3.PubMedCrossRefGoogle Scholar
  23. 23.
    Freitag L, Ernst A, Thomas M, et al. Sequential photodynamic therapy (PDT) and high dose brachytherapy for endobronchial tumour control in patients with limited bronchogenic carcinoma. Thorax. 2004;59:790–3.PubMedCrossRefGoogle Scholar
  24. 24.
    McCaughan JS. Survival after photodynamic therapy to non-pulmonary metastatic endobronchial tumors. Lasers Surg Med. 1999;24:194–201.PubMedCrossRefGoogle Scholar
  25. 25.
    Litle VR, Christie NA, Fernando HC, et al. Photodynamic therapy for endobronchial metastases from nonbronchogenic primaries. Ann Thorac Surg. 2003;76:370–5.PubMedCrossRefGoogle Scholar
  26. 26.
    Reddy C, Michaud G, Majid A, et al. Photodynamic therapy in the management of endobronchial metastatic lesions from renal cell carcinoma. J Bronchol Inter Pulmonol. 2009;16:245–9.CrossRefGoogle Scholar
  27. 27.
    PHOTOFRIN® (porfimer sodium) injection US Package Insert, August 2008.Google Scholar

Copyright information

© Springer Science+Business Media New York 2013

Authors and Affiliations

  1. 1.Respiratory, Critical Care and Occupational PulmonaryMedicine University of Utah Health Sciences CenterSalt Lake CityUSA

Personalised recommendations